ArticleOpen access Macedonian journal of medical sciences2019
Complications and Risks of Percutaneous Renal Biopsy.
Article in Open access Macedonian journal of medical sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.
- Metabolome panels as potential noninvasive biomarkers for primary glomerulonephritis sub-types: meta-analysis of profiling metabolomics studies.Scientific reports · 2023Pooled it
- Transjugular Renal Biopsy Bleeding Risk and Diagnostic Yield: A Systematic Review.Journal of vascular and interventional radiology : JVIR · 2020Pooled it
- Development of a novel combined nomogram model integrating deep learning radiomics to diagnose IgA nephropathy clinically.Renal failure · 2023Trial
- Renal elasticity assessment in patients of glomerulonephritis by shear-wave elastography and its correlation with histopathology and renal biomarkers.World journal of nephrology · 2026Article
- The Role of Keratin in the Mechanisms of Kidney Diseases.BioMed research international · 2026Review
- A Prospective Pilot Study to Investigate Whether Donor-Derived Cell-Free DNA Can Be Used as a Biomarker of Recurrent IgA Nephropathy Post-Kidney Transplantation.International journal of immunogenetics · 2025Article
- Multiparametric ultrasound for non-invasive evaluation of kidney graft function.Journal of ultrasound · 2025Observational
- What Is the Safe Observation Period Following Image-Guided Percutaneous Renal Biopsies?Journal of medical imaging and radiation oncology · 2025Article
- Sonological predictors of complications of percutaneous renal biopsy-a prospective observational study.Irish journal of medical science · 2024Observational
- Emergency endovascular and percutaneous urological interventions: A pictorial review.Emergency radiology · 2024Review
- Integrating shear wave elastography and estimated glomerular filtration rate to enhance diagnostic strategy for renal fibrosis assessment in chronic kidney disease.Quantitative imaging in medicine and surgery · 2024Article
- Frequency and timing of renal biopsy complications.Caspian journal of internal medicine · 2024Article
- Article
- Concordance of Solid Organ Biopsy Diagnoses With Hospital Autopsy and the Contribution of Biopsies to Death.Cureus · 2023Article
- Liquid biopsy for non-invasive monitoring of patients with kidney transplants.Frontiers in transplantation · 2023Review
- Prevalence of non-diabetic kidney disease and inability of clinical predictors to differentiate it from diabetic kidney disease: results from a prospectively performed renal biopsy study.BMJ open diabetes research & care · 2022Article
- A noninvasive artificial neural network model to predict IgA nephropathy risk in Chinese population.Scientific reports · 2022Article
- Predictors of perirenal haematoma post-percutaneous ultrasound-guided renal biopsy.The Journal of international medical research · 2021Article
- Evaluation of circulating tumor cell clusters for pan-cancer noninvasive diagnostic triaging.Cancer cytopathology · 2021Article
- Evaluation of percutaneous renal biopsy complications based on outcomes and indicators of the Nursing Outcomes Classification.Revista latino-americana de enfermagem · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRenal biopsy performed in native and transplant kidneys is generally considered a safe procedure.
aimIn this study, we evaluated renal biopsy complications and risk factors in one nephrology facility. MATERIAL AND
methodsWe conducted a three-year retrospective study on patients who underwent renal biopsy between January 2014 and December 2016. Strict written biopsy protocol was followed. Clinical and laboratory data were obtained from medical charts. Complications were categorised as minor and major, according to the need for intervention. Minor complications included macrohematuria and/or hematoma that did not require intervention. Major complications included hematuria or hematoma with fall of hematocrit that required a blood transfusion, surgery or caused death. A binary logistic regression model was used to analyse the possible factors associated with complications after the biopsy.
resultsWe analysed 345 biopsies; samples were taken from patients aged from 15-81 years, of whom 61% were men. A total of 21 (6%) patients developed a complication, 4.4% minor and 1.7% major complications. There were no nephrectomy or death due to biopsy intervention. Overweight patients, as well as those with higher creatinine, lower hemoglobin, higher blood pressure and biopsy due to AKI had higher chances to develop complications (p = 0.037, p = 0.023, p = 0.032, p = 0.002, p = 0.002, respectively). The patients' age, gender, kidney dimension, number of passes and uninterrupted aspirin therapy were not found as significant predictors of complications. In the multivariate logistic model, body weight (OR = 1.031, 95%CI = 1.002-1.062), lower hemoglobin (OR = 0.973, 95%CI = 0.951-0.996) and hypertension (OR = 1.025, 95%CI = 1.007-1.044) increased the risk of complications in biopsied patients.
conclusionRenal biopsy is a safe procedure with a low risk of complications when strict biopsy protocol is observed. Correction of anaemia and blood pressure is to be considered before the biopsy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.